Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The interactive web-based program MSmonitor for self-management and multidisciplinary care in multiple sclerosis: concept, content, and pilot results.
Evaluation of an albumin-binding gadolinium contrast agent in multiple sclerosis.
The benefits and risks of alemtuzumab in multiple sclerosis.
Ocular and cervical vestibular evoked myogenic potentials in patients with multiple sclerosis.
The effect of triiodothyronine on maturation and differentiation of oligodendrocyte progenitor cells during remyelination following induced demyelination in male albino rat.
Loss of retinal nerve fibre layer axons indicates white but not grey matter damage in early multiple sclerosis.
Regulatory T and B lymphocytes in a spontaneous autoimmune polyneuropathy.
The Use of Focus Groups to Characterize Symptoms in Persons With Multiple Sclerosis.
Evaluation of the effects of group psychotherapy on cognitive function in patients with multiple sclerosis with cognitive dysfunction and depression.
Vitamin D in multiple sclerosis patients: Not the same risk for everybody.
BENEFIT 8-year results provide further support for the long-term value of early treatment of multiple sclerosis.
The Role of 3-O-Sulfogalactosylceramide, Sulfatide, in the Lateral Organization of Myelin Membrane.
Characterization of immune response to neurofilament light in experimental autoimmune encephalomyelitis.
Reducing clinical trial risk in multiple sclerosis.
Goal oriented inpatient multiple sclerosis group.
Investigation of immune and CNS-mediated effects of fingolimod in the focal delayed-type hypersensitivity multiple sclerosis model.
Multiple sclerosis.
Fostering adherence to injectable disease-modifying therapies in multiple sclerosis.
Biomarkers of Inflammation and Axonal Degeneration/Damage in Patients with Newly Diagnosed Multiple Sclerosis: Contributions of the Soluble CD163 CSF/Serum Ratio to a Biomarker Panel.
Posterior Reversible Encephalopathy Syndrome due to High Dose Corticosteroids for an MS Relapse.
Involvement of aquaporin 4 in astrocyte function and neuropsychiatric disorders.
Altered resting-state functional connectivity in cognitively preserved pediatric-onset MS patients and relationship to structural damage and cognitive performance.
Brain glycolipids suppress T helper cells and inhibit autoimmune demyelination.
Oligodendrocyte Precursor Cells in Spinal Cord Injury: A Review and Update.
Relapsing optic neuritis: a multicentre study of 62 patients.
Pages
« first
‹ previous
…
447
448
449
450
451
452
453
454
455
…
next ›
last »